Research News and Research

RSS

Lawmakers return to Washington to face the 'fiscal cliff'

As interest groups ranging from business lobbies to AARP mobilize to protect their constituencies, some Democrats acknowledge that Medicare and Medicaid need to be part of the conversation.

26 Nov 2012

Overexpressed enzyme contributes to development of preeclampsia

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine.

26 Nov 2012

Two new studies explore how laws, advertising impact cancer costs

Reuters reports on two new studies regarding cancer treatment costs, including findings that laws don't curb the use of pricey prostate cancer treatments and that ads don't increase the use of aromatase inhibitors for breast cancer.

26 Nov 2012

Elsevier announces launch of Leukemia Research Reports journal

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new open access, online journal, Leukemia Research Reports.

26 Nov 2012

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Seattle Genetics, Inc. announced today that ADCETRIS (brentuximab vedotin) has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of mycosis fungoides (MF). MF is the most common type of cutaneous T-cell lymphoma (CTCL).

26 Nov 2012

Pediatricians called to prescribe 'morning-after' pills in advance

Wading into the incendiary subject of birth control for young teenagers, the American Academy of Pediatrics (AAP) on Monday called on the nation's pediatricians to counsel all of their adolescent patients about emergency contraception and make advance prescriptions for it available to girls under 17.

26 Nov 2012

Bruker combines nanoscale AFM zoom capabilities with high-throughput 3D optical microscopy

Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of the unique NanoLens Atomic Force Microscope (AFM) accessory for ContourGT 3D optical microscopes.

From Bruker Nano Surfaces and Metrology 26 Nov 2012

Avermectin family of drugs shows promise against TB

A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.

26 Nov 2012

Plan to pay less for certain diagnostic tests draws fire

Neurologists in Boston and nationwide are objecting to a plan that would pay them less for certain diagnostic tests, a change meant to cut Medicare costs and direct more money to primary care physicians whose pay is widely seen as inadequate even before they take on more work under the national health care overhaul.

26 Nov 2012

Bruker releases new line of IRIS TERS Probes

Bruker announced today at the 2012 Materials Research Society (MRS) Fall Meeting the release of a new line of IRIS TERS Probes. By enabling Tip-Enhanced Raman Spectroscopy (TERS), the new IRIS TERS probe tips provide users a complete path to non-destructive, label-free chemical detection at the nanoscale.

From Bruker Nano Surfaces and Metrology 26 Nov 2012

Changes in health care deductions soon to kick in

The Wall Street Journal examines key changes in the health insurance marketplace for which consumers should be prepared.

26 Nov 2012

Enrollment complete in Tryton's Pivotal IDE Side Branch Stent trial to treat bifurcation lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.

26 Nov 2012

New therapeutic approach for preventing Alzheimer's disease

Pathological changes typical of Alzheimer's disease were significantly reduced in mice by blockade of an immune system transmitter. A research team from Charité - Universitätsmedizin Berlin and the University of Zurich has just published a new therapeutic approach in fighting Alzheimer's disease in the current issue of Nature Medicine. This approach promises potential in prevention, as well as in cases where the disease has already set in.

26 Nov 2012

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

Inovio Pharmaceuticals, Inc. announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV is also associated with numerous inflammatory diseases and cancers, and is implicated in hypertension, a major risk factor for cardiovascular diseases.

26 Nov 2012

First Edition: November 26, 2012

Today's headlines include a range of stories regarding the future of the "fiscal cliff" negotiations as well as reports about the strategies that might now be used by health law opponents.

26 Nov 2012

Negative messages not having an impact in people with addictive behaviors

What types of public messages will most likely deter drug and alcohol abuse or dissuade people from engaging in risky behavior? Negatively framed messages may not be an effective way to reach those most in need of persuasion, suggests a new study in Psychology of Addictive Behaviors by researchers from Indiana University and Wayne State University.

26 Nov 2012